findmyKOL

Christopher Rembold, MD

Basic profile

Charlottesville Medical Research

ORCIDNPI
RegionCharlottesville, VA · SoutheastSpecialtyCardiovascular DiseaseFocusCardiology
Last active 2015findmyKOL typefindmyKOL type: our influence ranking, shown when you reveal the full profileLatest publication2015Online presenceNot yet checkedPaymentsNone reportedNIH funding1987–2008Why? →

Christopher Rembold is a Cardiology physician affiliated with Charlottesville Medical Research. OpenAlex indexes 138 publications with 8,027 citations (h-index 40).

Overview

Scholarship

indexed output and impact (OpenAlex)
View publications ↓
138publications

Distinct works indexed by OpenAlex, matched via ORCID.

8,027citations

Total citations across indexed works.

40h-index

Hirsch index, productivity × impact (OpenAlex).

Clinical & industry

trials, payments and federal funding
6NIH grants · 1987–2008

Federally funded research awards.

View funding

Contact

The practice address and phone this provider lists in the federal NPPES (CMS) registry.

Practice address

500 Ray C Hunt Dr
Charlottesville, VA 229032981

Telephone

434-243-1000

Provider last certified this registry record 13 Sept 2023.

View the NPPES registry record

Medicare prescribing footprint (2024)

The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.

  • Cardiovascular

    92.8%
    Statin22.2%
    Rosuvastatin Calcium69%Simvastatin13%Atorvastatin Calcium12%Pravastatin Sodium6%
    Part D<11 patients
    Cholesterol absorption inhibitor14.9%
    Ezetimibe100%
    Part D40 patients

    + 8 more classes in this area

  • Metabolism & gastrointestinal

    5.4%
    Nicotinic Acid2.8%
    Niacin Er100%
    Part D<11 patients
    Biguanide (metformin)2.6%
    Metformin Hcl Er100%
    Part D<11 patients
  • Blood & clotting

    1.8%
    Factor Xa inhibitor1.8%
    Eliquis100%
    Part D<11 patients
Where care is delivered (Part B)36.5% facility · 63.5% office

Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.

NIH funding

6 NIH research awards on record, funded 19872008 per NIH RePORTER. The latest:

Awards in the NIH RePORTER records where a principal investigator name matches this physician at an organization in their practice state. Latest award years shown; each row links to the project record on RePORTER.

Publications

Matched to this physician's OpenAlex author record; most-cited works shown first.

Similar KOLs

Other experts from the same institution or the same specialty.

A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”